Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis
Osteoarthritis (OA) has long been viewed as a degenerative disease of cartilage, but
accumulating evidence indicates that inflammation has a critical role in its pathogenesis …
accumulating evidence indicates that inflammation has a critical role in its pathogenesis …
Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage–bone crosstalk
SR Goldring, MB Goldring - Nature Reviews Rheumatology, 2016 - nature.com
In diarthrodial joints, the articular cartilage, calcified cartilage, and subchondral cortical and
trabecular bone form a biocomposite—referred to as the osteochondral unit—that is …
trabecular bone form a biocomposite—referred to as the osteochondral unit—that is …
[HTML][HTML] Chondrocyte and mesenchymal stem cell-based therapies for cartilage repair in osteoarthritis and related orthopaedic conditions
Osteoarthritis (OA) represents a final and common pathway for all major traumatic insults to
synovial joints. OA is the most common form of degenerative joint disease and a major …
synovial joints. OA is the most common form of degenerative joint disease and a major …
Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics
Introduction: Osteoarthritis (OA) is a leading cause of pain and disability among adults with a
current prevalence of around 15% and a predicted prevalence of 35% in 2030 for …
current prevalence of around 15% and a predicted prevalence of 35% in 2030 for …
Senescent cells and osteoarthritis: a painful connection
OH Jeon, N David, J Campisi… - The Journal of clinical …, 2018 - Am Soc Clin Investig
Senescent cells (SnCs) are associated with age-related pathologies. Osteoarthritis is a
chronic disease characterized by pain, loss of cartilage, and joint inflammation, and its …
chronic disease characterized by pain, loss of cartilage, and joint inflammation, and its …
Adipose, bone marrow and synovial joint-derived mesenchymal stem cells for cartilage repair
Current cell-based repair strategies have proven unsuccessful for treating cartilage defects
and osteoarthritic lesions, consequently advances in innovative therapeutics are required …
and osteoarthritic lesions, consequently advances in innovative therapeutics are required …
Chitosan oligosaccharides packaged into rat adipose mesenchymal stem cells-derived extracellular vesicles facilitating cartilage injury repair and alleviating …
S Li, J Liu, S Liu, W Jiao, X Wang - Journal of Nanobiotechnology, 2021 - Springer
Objectives This study aimed to investigate the roles of adipose mesenchymal stem cell
(AMSC)-derived extracellular vesicles (EVs) binding with chitosan oligosaccharides (COS) …
(AMSC)-derived extracellular vesicles (EVs) binding with chitosan oligosaccharides (COS) …
[HTML][HTML] Osteoarthritis Year in Review 2016: biomarkers (biochemical markers)
A Mobasheri, AC Bay-Jensen, WE Van Spil… - Osteoarthritis and …, 2017 - Elsevier
Purpose The aim of this “Year in Review” article is to summarize and discuss the
implications of biochemical marker related articles published between the Osteoarthritis …
implications of biochemical marker related articles published between the Osteoarthritis …
Emerging targets in osteoarthritis therapy
MB Goldring, F Berenbaum - Current opinion in pharmacology, 2015 - Elsevier
Highlights•Different OA etiologies present a challenge for developing a single targeted
therapy.•Common mechanisms occur in inflammatory, mechanical, and oxidative stress in …
therapy.•Common mechanisms occur in inflammatory, mechanical, and oxidative stress in …
Is osteoarthritis one disease or a collection of many?
LA Deveza, RF Loeser - Rheumatology, 2018 - academic.oup.com
OA is a multifaceted and heterogeneous syndrome that may be amenable to tailored
treatment. There has been an increasing focus within the OA research community on the …
treatment. There has been an increasing focus within the OA research community on the …